1,667 Shares in Sanofi (NASDAQ:SNY) Acquired by ORG Wealth Partners LLC

ORG Wealth Partners LLC bought a new position in shares of Sanofi (NASDAQ:SNY) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,667 shares of the company’s stock, valued at approximately $91,000.

Other large investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD boosted its stake in Sanofi by 88.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,843,682 shares of the company’s stock worth $522,991,000 after purchasing an additional 5,091,304 shares during the period. Raymond James Financial Inc. acquired a new position in Sanofi in the 4th quarter worth approximately $135,933,000. Boston Partners boosted its stake in Sanofi by 86.4% in the 4th quarter. Boston Partners now owns 5,396,531 shares of the company’s stock worth $260,607,000 after purchasing an additional 2,501,073 shares during the period. Magnetar Financial LLC boosted its stake in Sanofi by 104.3% in the 4th quarter. Magnetar Financial LLC now owns 3,340,317 shares of the company’s stock worth $161,103,000 after purchasing an additional 1,705,148 shares during the period. Finally, Point72 Asset Management L.P. boosted its stake in Sanofi by 969.6% in the 4th quarter. Point72 Asset Management L.P. now owns 950,649 shares of the company’s stock worth $45,850,000 after purchasing an additional 861,770 shares during the period. 14.04% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Morgan Stanley set a $56.00 price objective on shares of Sanofi in a research note on Monday, June 2nd. BNP Paribas assumed coverage on shares of Sanofi in a research note on Tuesday, April 15th. They issued an “outperform” rating and a $65.00 price objective for the company. The Goldman Sachs Group assumed coverage on shares of Sanofi in a research note on Friday, March 21st. They issued a “neutral” rating and a $65.00 price objective for the company. Hsbc Global Res raised shares of Sanofi to a “strong-buy” rating in a research note on Monday, April 28th. Finally, Guggenheim reiterated a “buy” rating on shares of Sanofi in a research report on Tuesday, June 3rd. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat, Sanofi has a consensus rating of “Buy” and an average target price of $61.50.

Sanofi Stock Up 0.5%

SNY stock opened at $47.86 on Friday. Sanofi has a 12-month low of $45.80 and a 12-month high of $60.12. The company has a quick ratio of 0.69, a current ratio of 1.37 and a debt-to-equity ratio of 0.16. The company has a market cap of $117.37 billion, a price-to-earnings ratio of 17.09, a PEG ratio of 0.98 and a beta of 0.50. The company has a 50 day moving average of $51.23 and a two-hundred day moving average of $52.00.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, April 24th. The company reported $0.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.04. The company had revenue of $10.41 billion during the quarter, compared to the consensus estimate of $9.79 billion. Sanofi had a net margin of 14.56% and a return on equity of 17.15%. The company’s revenue was down 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.78 EPS. On average, equities analysts anticipate that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The firm also recently declared an annual dividend, which was paid on Thursday, June 12th. Stockholders of record on Friday, May 9th were issued a dividend of $2.0369 per share. The ex-dividend date was Friday, May 9th. This represents a dividend yield of 3.1%. This is an increase from Sanofi’s previous annual dividend of $1.48. Sanofi’s dividend payout ratio (DPR) is currently 57.14%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.